RPTX - Repare Therapeutics Inc
2.65
0.020 0.755%
Share volume: 1,219,919
Last Updated: 01-27-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$2.63
0.02
0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-07-2024 | 08-06-2024 | 11-07-2024 | 03-03-2025 | 05-13-2025 | 11-14-2025 | |
| Total revenue | 52.404 M | 1.073 M | 0.000 | 0.000 | 0.000 | 11.620 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 52.404 M | 1.073 M | 0.000 | 0.000 | 0.000 | 11.620 M | |
| -97.95% | -100.00% | nan% | inf% | ||||
| Operating expenses | 41.588 M | 38.392 M | 34.845 M | 30.796 M | 27.922 M | 12.050 M | |
| Selling general and admin | 8.618 M | 8.317 M | 6.444 M | 6.301 M | 7.652 M | 4.548 M | |
| Research and development | 32.970 M | 30.075 M | 28.401 M | 24.495 M | 20.270 M | 7.502 M | |
| Total expenses | 41.588 M | 38.392 M | 36.372 M | 30.648 M | 31.187 M | 10.489 M | |
| -7.68% | -5.26% | -15.74% | 1.76% | -66.37% | |||
| Operating income | 10.816 M | -37.319 M | -36.372 M | -30.648 M | -31.187 M | 1.131 M | |
| Ebit | 10.816 M | -37.342 M | -36.433 M | -30.688 M | -31.211 M | 1.179 M | |
| Pretax income | 13.791 M | -34.448 M | -33.921 M | -28.671 M | -29.673 M | 3.403 M | |
| -349.79% | -1.53% | -15.48% | 3.49% | -111.47% | |||
| Income tax | 629.000 K | 326.000 K | 485.000 K | 0.000 | 370.000 K | 145.000 K | |
| Net income basic | 13.162 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| -100.00% | |||||||
| Net income | 13.162 M | -34.774 M | -34.406 M | -28.671 M | -30.043 M | 3.258 M | |
| -364.20% | 1.06% | 16.67% | -4.79% | 110.84% |